The Needle Biopsy Market is projected to reach US$ 2.45 Billion by 2031, registering a CAGR of 6.5% during 2025–2031. The market is expanding as healthcare providers increasingly rely on minimally invasive tissue sampling techniques to support the diagnosis and evaluation of cancer and other diseases. Growth is supported by the rising burden of cancer, increasing...